These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

500 related items for PubMed ID: 11255384

  • 1. Continuation pharmacotherapy in the prevention of relapse following electroconvulsive therapy: a randomized controlled trial.
    Sackeim HA, Haskett RF, Mulsant BH, Thase ME, Mann JJ, Pettinati HM, Greenberg RM, Crowe RR, Cooper TB, Prudic J.
    JAMA; 2001 Mar 14; 285(10):1299-307. PubMed ID: 11255384
    [Abstract] [Full Text] [Related]

  • 2. Continuation electroconvulsive therapy vs pharmacotherapy for relapse prevention in major depression: a multisite study from the Consortium for Research in Electroconvulsive Therapy (CORE).
    Kellner CH, Knapp RG, Petrides G, Rummans TA, Husain MM, Rasmussen K, Mueller M, Bernstein HJ, O'Connor K, Smith G, Biggs M, Bailine SH, Malur C, Yim E, McClintock S, Sampson S, Fink M.
    Arch Gen Psychiatry; 2006 Dec 14; 63(12):1337-44. PubMed ID: 17146008
    [Abstract] [Full Text] [Related]

  • 3. Relapse during continuation pharmacotherapy after acute response to ECT: a comparison of usual care versus protocolized treatment.
    Tew JD, Mulsant BH, Haskett RF, Joan P, Begley AE, Sackeim HA.
    Ann Clin Psychiatry; 2007 Dec 14; 19(1):1-4. PubMed ID: 17453654
    [Abstract] [Full Text] [Related]

  • 4. Is baseline medication resistance associated with potential for relapse after successful remission of a depressive episode with ECT? Data from the Consortium for Research on Electroconvulsive Therapy (CORE).
    Rasmussen KG, Mueller M, Rummans TA, Husain MM, Petrides G, Knapp RG, Fink M, Sampson SM, Bailine SH, Kellner CH.
    J Clin Psychiatry; 2009 Feb 14; 70(2):232-7. PubMed ID: 19192459
    [Abstract] [Full Text] [Related]

  • 5. Health-related quality of life in a clinical trial of ECT followed by continuation pharmacotherapy: effects immediately after ECT and at 24 weeks.
    McCall WV, Rosenquist PB, Kimball J, Haskett R, Isenberg K, Prudic J, Lasater B, Sackeim HA.
    J ECT; 2011 Jun 14; 27(2):97-102. PubMed ID: 21206285
    [Abstract] [Full Text] [Related]

  • 6. Pharmacological strategies in the prevention of relapse after electroconvulsive therapy.
    Prudic J, Haskett RF, McCall WV, Isenberg K, Cooper T, Rosenquist PB, Mulsant BH, Sackeim HA.
    J ECT; 2013 Mar 14; 29(1):3-12. PubMed ID: 23303417
    [Abstract] [Full Text] [Related]

  • 7. Continuation electroconvulsive therapy with pharmacotherapy versus pharmacotherapy alone for prevention of relapse of depression: a randomized controlled trial.
    Nordenskjöld A, von Knorring L, Ljung T, Carlborg A, Brus O, Engström I.
    J ECT; 2013 Jun 14; 29(2):86-92. PubMed ID: 23303421
    [Abstract] [Full Text] [Related]

  • 8. Effect of concomitant pharmacotherapy on electroconvulsive therapy outcomes: short-term efficacy and adverse effects.
    Sackeim HA, Dillingham EM, Prudic J, Cooper T, McCall WV, Rosenquist P, Isenberg K, Garcia K, Mulsant BH, Haskett RF.
    Arch Gen Psychiatry; 2009 Jul 14; 66(7):729-37. PubMed ID: 19581564
    [Abstract] [Full Text] [Related]

  • 9. Nortriptyline and interpersonal psychotherapy as maintenance therapies for recurrent major depression: a randomized controlled trial in patients older than 59 years.
    Reynolds CF, Frank E, Perel JM, Imber SD, Cornes C, Miller MD, Mazumdar S, Houck PR, Dew MA, Stack JA, Pollock BG, Kupfer DJ.
    JAMA; 1999 Jan 06; 281(1):39-45. PubMed ID: 9892449
    [Abstract] [Full Text] [Related]

  • 10. Data management and design issues in an unmasked randomized trial of electroconvulsive therapy for relapse prevention of severe depression: the consortium for research in electroconvulsive therapy trial.
    Rasmussen KG, Knapp RG, Biggs MM, Smith GE, Rummans TA, Petrides G, Husain MM, O'Connor MK, Fink M, Kellner CH.
    J ECT; 2007 Dec 06; 23(4):244-50. PubMed ID: 18090697
    [Abstract] [Full Text] [Related]

  • 11. A randomized controlled trial comparing the memory effects of continuation electroconvulsive therapy versus continuation pharmacotherapy: results from the Consortium for Research in ECT (CORE) study.
    Smith GE, Rasmussen KG, Cullum CM, Felmlee-Devine MD, Petrides G, Rummans TA, Husain MM, Mueller M, Bernstein HJ, Knapp RG, O'Connor MK, Fink M, Sampson S, Bailine SH, Kellner CH, CORE Investigators.
    J Clin Psychiatry; 2010 Feb 06; 71(2):185-93. PubMed ID: 20193646
    [Abstract] [Full Text] [Related]

  • 12. Imipramine is effective in preventing relapse in electroconvulsive therapy-responsive depressed inpatients with prior pharmacotherapy treatment failure: a randomized, placebo-controlled trial.
    van den Broek WW, Birkenhäger TK, Mulder PG, Bruijn JA, Moleman P.
    J Clin Psychiatry; 2006 Feb 06; 67(2):263-8. PubMed ID: 16566622
    [Abstract] [Full Text] [Related]

  • 13. Continuation/maintenance treatment with nortriptyline versus combined nortriptyline and ECT in late-life psychotic depression: a two-year randomized study.
    Navarro V, Gastó C, Torres X, Masana G, Penadés R, Guarch J, Vázquez M, Serra M, Pujol N, Pintor L, Catalán R.
    Am J Geriatr Psychiatry; 2008 Jun 06; 16(6):498-505. PubMed ID: 18515694
    [Abstract] [Full Text] [Related]

  • 14. Influence of adjuvant nortriptyline on the efficacy of electroconvulsive therapy: A randomized controlled trial and 1-year follow-up.
    Pluijms EM, Kamperman AM, Hoogendijk WJG, van den Broek WW, Birkenhäger TK.
    Acta Psychiatr Scand; 2022 May 06; 145(5):517-528. PubMed ID: 35152416
    [Abstract] [Full Text] [Related]

  • 15. Two-year outcome of psychotic depression in late life.
    Flint AJ, Rifat SL.
    Am J Psychiatry; 1998 Feb 06; 155(2):178-83. PubMed ID: 9464195
    [Abstract] [Full Text] [Related]

  • 16. [Maintenance electroconvulsive therapy in elderly psychotic unipolar depression].
    Serra M, Gastó C, Navarro V, Torres X, Blanch J, Masana G.
    Med Clin (Barc); 2006 Apr 08; 126(13):491-2. PubMed ID: 16624227
    [Abstract] [Full Text] [Related]

  • 17. Relapse Prevention in Major Depressive Disorder After Successful Acute Electroconvulsive Treatment: a 6-month Double-blind Comparison of Three Fixed Dosages of Escitalopram and a Fixed Dose of Nortriptyline - Lessons from a Failed Randomised Trial of the Danish University Antidepressant Group (DUAG-7).
    Martiny K, Larsen ER, Licht RW, Nielsen CT, Damkier P, Refsgaard E, Lunde M, Straasø B, Christensen EM, Lolk A, Holmskov J, Sørensen CH, Brødsgaard I, Eftekhari SZ, Bendsen BB, Klysner R, Terp IM, Larsen JK, Vestergaard P, Buchholtz PE, Gram LF, Bech P, Danish University Antidepressant Group (DUAG*).
    Pharmacopsychiatry; 2015 Nov 08; 48(7):274-8. PubMed ID: 26529118
    [Abstract] [Full Text] [Related]

  • 18. Combination of pharmacotherapy with electroconvulsive therapy in prevention of depressive relapse: a pilot controlled trial.
    Yildiz A, Mantar A, Simsek S, Onur E, Gökmen N, Fidaner H.
    J ECT; 2010 Jun 08; 26(2):104-10. PubMed ID: 19935091
    [Abstract] [Full Text] [Related]

  • 19. Relapse following bitemporal and high-dose right unilateral electroconvulsive therapy for major depression.
    Jelovac A, Kolshus E, McLoughlin DM.
    Acta Psychiatr Scand; 2021 Sep 08; 144(3):218-229. PubMed ID: 34033117
    [Abstract] [Full Text] [Related]

  • 20. The treatment of psychotic depression in later life: a comparison of pharmacotherapy and ECT.
    Flint AJ, Rifat SL.
    Int J Geriatr Psychiatry; 1998 Jan 08; 13(1):23-8. PubMed ID: 9489577
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.